3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
100
Glioma
42
Brain Neoplasms
28
Neuroblastoma
25
Astrocytoma
18
Gliosarcoma
15
Sarcoma, Ewing
12
Rhabdomyosarcoma
12
Neoplasms
12
Recurrence
11
Medulloblastoma
11
Small Cell Lung Carcinoma
8
Sarcoma
8
Oligodendroglioma
8
Melanoma
7
Osteosarcoma
6
Ependymoma
6
Diffuse Intrinsic Pontine Glioma
6
Central Nervous System Neoplasms
4
Rhabdoid Tumor
3
Prostatic Neoplasms
3
Neuroendocrine Tumors
3
Neuroectodermal Tumors, Primitive
3
Neoplasm Metastasis
3
Lymphoma, Follicular
3
Lymphoma
3
Lung Neoplasms
3
Ganglioneuroblastoma
3
Desmoplastic Small Round Cell Tumor
3
Colorectal Neoplasms
3
Interventions
pembrolizumab
243
Carboplatin
211
Pemetrexed
177
Cisplatin
131
Paclitaxel
113
Nivolumab
101
Docetaxel
87
osimertinib
85
durvalumab
78
Specimen Handling
56
atezolizumab
55
Gemcitabine
52
Drug Therapy
52
Magnetic Resonance Spectroscopy
50
Radiosurgery
48
Radiotherapy
47
Ipilimumab
41
130-nm albumin-bound paclitaxel
39
cemiplimab
38
Bevacizumab
34
Cetuximab
30
tislelizumab
29
amivantamab
22
Taxes
22
Platinum Compounds
20
Blood Specimen Collection
20
Immunotherapy
18
Immune Checkpoint Inhibitors
18
Radiation
17
Erlotinib Hydrochloride
17
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Non-Small-Cell Lung
×
Temozolomide
×
1 year
×
Clear all
No trials found.